• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新评估和校准癌症合并发热性中性粒细胞减少症患儿细菌感染的预测指标。

Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia.

作者信息

Haeusler Gabrielle M, Phillips Robert, Slavin Monica A, Babl Franz E, De Abreu Lourenco Richard, Mechinaud Francoise, Thursky Karin A

机构信息

Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia.

NHMRC National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.

出版信息

EClinicalMedicine. 2020 Jun 15;23:100394. doi: 10.1016/j.eclinm.2020.100394. eCollection 2020 Jun.

DOI:10.1016/j.eclinm.2020.100394
PMID:32637894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7329706/
Abstract

BACKGROUND

Numerous paediatric febrile neutropenia (FN) clinical decision rules (CDRs) have been derived. Validation studies show reduced performance in external settings. We evaluated the association between variables common across published FN CDRs and bacterial infection and recalibrated existing CDRs using these data.

METHODS

Prospective data from the Australian-PICNICC study which enrolled 858 FN episodes in children with cancer were used. Variables shown to be significant predictors of infection or adverse outcome in >1 CDR were analysed using multivariable logistic regression. Recalibration included re-evaluation of beta-coefficients (logistic model) or recursive-partition analysis (tree-based models).

FINDINGS

Twenty-five unique variables were identified across 17 FN CDRs. Fourteen were included in >1 CDR and 10 were analysed in our dataset. On univariate analysis, location, temperature, hypotension, rigors, severely unwell and decreasing platelets, white cell count, neutrophil count and monocyte count were significantly associated with bacterial infection. On multivariable analysis, decreasing platelets, increasing temperature and the appearance of being clinically unwell remained significantly associated. Five rules were recalibrated. Across all rules, recalibration increased the AUC-ROC and low-risk yield as compared to non-recalibrated data. For the SPOG-adverse event CDR, recalibration also increased sensitivity and specificity and external validation showed reproducibility.

INTERPRETATION

Degree of marrow suppression (low platelets), features of inflammation (temperature) and clinical judgement (severely unwell) have been consistently shown to predict infection in children with FN. Recalibration of existing CDRs is a novel way to improve diagnostic performance of CDRs and maintain relevance over time.

FUNDING

National Health and Medical Research Council Grant (APP1104527).

摘要

背景

已得出众多儿童发热性中性粒细胞减少症(FN)临床决策规则(CDR)。验证研究表明,这些规则在外部环境中的表现有所下降。我们评估了已发表的FN CDR中常见变量与细菌感染之间的关联,并利用这些数据对现有CDR进行重新校准。

方法

使用澳大利亚-儿童国际癌症中性粒细胞减少症研究(Australian-PICNICC study)的前瞻性数据,该研究纳入了858例癌症患儿的FN发作。对在>1个CDR中显示为感染或不良结局显著预测因素的变量进行多变量逻辑回归分析。重新校准包括对β系数(逻辑模型)或递归划分分析(基于树的模型)进行重新评估。

结果

在17个FN CDR中识别出25个独特变量。14个变量包含在>1个CDR中,10个变量在我们的数据集中进行了分析。单变量分析显示,部位、体温、低血压、寒战、严重不适以及血小板、白细胞计数、中性粒细胞计数和单核细胞计数下降与细菌感染显著相关。多变量分析显示,血小板减少、体温升高和临床不适表现仍显著相关。对5条规则进行了重新校准。与未重新校准的数据相比,重新校准提高了所有规则的曲线下面积(AUC-ROC)和低风险率。对于SPOG不良事件CDR,重新校准还提高了敏感性和特异性,外部验证显示具有可重复性。

解读

骨髓抑制程度(血小板低)、炎症特征(体温)和临床判断(严重不适)一直被证明可预测FN患儿的感染情况。对现有CDR进行重新校准是提高CDR诊断性能并长期保持相关性的一种新方法。

资助

国家卫生与医学研究委员会拨款(APP1104527)。

相似文献

1
Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia.重新评估和校准癌症合并发热性中性粒细胞减少症患儿细菌感染的预测指标。
EClinicalMedicine. 2020 Jun 15;23:100394. doi: 10.1016/j.eclinm.2020.100394. eCollection 2020 Jun.
2
Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.一种用于预测癌症治疗儿童发热性中性粒细胞减少症期间严重感染风险的新临床决策规则(DISCERN-FN)的决策树推导及外部验证
Lancet Child Adolesc Health. 2022 Apr;6(4):260-268. doi: 10.1016/S2352-4642(21)00337-0. Epub 2021 Dec 3.
3
Outcome prediction in pediatric fever in neutropenia: Development of clinical decision rules and external validation of published rules based on data from the prospective multicenter SPOG 2015 FN definition study.中性粒细胞减少症儿童发热的预后预测:基于前瞻性多中心 SPOG 2015 FN 定义研究数据,制定临床决策规则并对已发表规则进行外部验证。
PLoS One. 2023 Aug 2;18(8):e0287233. doi: 10.1371/journal.pone.0287233. eCollection 2023.
4
Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules.癌症合并发热性中性粒细胞减少症患儿的风险分层:九种临床决策规则的全国性、前瞻性、多中心验证
EClinicalMedicine. 2020 Jan 7;18:100220. doi: 10.1016/j.eclinm.2019.11.013. eCollection 2020 Jan.
5
The Performance of the Australian-UK-Swiss Clinical Decision Rule for Febrile Neutropenia in Children and Young Adults With Bone and Soft Tissue Sarcomas.澳大利亚-英国-瑞士儿童和青年骨肉瘤及软组织肉瘤发热性中性粒细胞减少症临床决策规则的性能
Pediatr Blood Cancer. 2025 Jun;72(6):e31651. doi: 10.1002/pbc.31651. Epub 2025 Mar 10.
6
External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules.六种儿科发热伴中性粒细胞减少症临床决策规则的外部验证。
Pediatr Infect Dis J. 2018 Apr;37(4):329-335. doi: 10.1097/INF.0000000000001777.
7
Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodes.抗生素使用时间对儿童发热性中性粒细胞减少症临床结局的影响:1685例病例的目标试验模拟
Lancet Reg Health West Pac. 2024 Nov 2;53:101226. doi: 10.1016/j.lanwpc.2024.101226. eCollection 2024 Dec.
8
Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study.预测癌症患儿的感染并发症:一项外部验证研究。
Br J Cancer. 2017 Jul 11;117(2):171-178. doi: 10.1038/bjc.2017.154. Epub 2017 Jun 13.
9
Which decision rules meet methodological standards in children with febrile neutropenia? Results of a systematic review and analysis.哪些决策规则符合发热性中性粒细胞减少症儿童的方法学标准?系统评价和分析的结果。
Pediatr Blood Cancer. 2014 Oct;61(10):1786-91. doi: 10.1002/pbc.25106. Epub 2014 Jun 29.
10
Predicting the risk of severe infection in children with chemotherapy-induced febrile neutropenia.预测化疗引起的发热性中性粒细胞减少症患儿严重感染的风险。
Curr Opin Hematol. 2012 Jan;19(1):39-43. doi: 10.1097/MOH.0b013e32834da951.

引用本文的文献

1
Fever in Children with Cancer: Pathophysiological Insights Using Blood Transcriptomics.癌症患儿发热:基于血液转录组学的病理生理学见解
Int J Mol Sci. 2025 Jul 24;26(15):7126. doi: 10.3390/ijms26157126.
2
Clinical Decision Support to Reduce Hospital Length-of-Stay for Cancer Patients with Fever and Neutropenia.用于缩短癌症发热性中性粒细胞减少症患者住院时间的临床决策支持
Appl Clin Inform. 2025 May;16(3):538-543. doi: 10.1055/a-2540-2349. Epub 2025 Feb 18.
3
Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodes.抗生素使用时间对儿童发热性中性粒细胞减少症临床结局的影响:1685例病例的目标试验模拟
Lancet Reg Health West Pac. 2024 Nov 2;53:101226. doi: 10.1016/j.lanwpc.2024.101226. eCollection 2024 Dec.
4
Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia.识别急性髓系白血病成人患者低风险发热性中性粒细胞减少症入院的预测因素。
Blood Adv. 2024 Dec 24;8(24):6161-6170. doi: 10.1182/bloodadvances.2024014291.
5
Economic implications of step-down outpatient management for fever and neutropenia episodes in pediatric cancer patients: a cost minimization analysis.儿童癌症患者发热和中性粒细胞减少症门诊降阶梯管理的经济影响:成本最小化分析。
BMC Health Serv Res. 2024 Aug 24;24(1):981. doi: 10.1186/s12913-024-11442-w.
6
Outcome prediction in pediatric fever in neutropenia: Development of clinical decision rules and external validation of published rules based on data from the prospective multicenter SPOG 2015 FN definition study.中性粒细胞减少症儿童发热的预后预测:基于前瞻性多中心 SPOG 2015 FN 定义研究数据,制定临床决策规则并对已发表规则进行外部验证。
PLoS One. 2023 Aug 2;18(8):e0287233. doi: 10.1371/journal.pone.0287233. eCollection 2023.
7
Does Fever Response to Acetaminophen Predict Bloodstream Infections in Febrile Neutropenia?对乙酰氨基酚的发热反应能否预测发热性中性粒细胞减少症患者的血流感染?
Cureus. 2023 Mar 26;15(3):e36712. doi: 10.7759/cureus.36712. eCollection 2023 Mar.
8
Can I go home now? The safety and efficacy of a new UK paediatric febrile neutropenia protocol for risk-stratified early discharge on oral antibiotics.我现在可以回家了吗?新的英国儿科发热性中性粒细胞减少症风险分层早期口服抗生素出院方案的安全性和有效性。
Arch Dis Child. 2023 Mar;108(3):192-197. doi: 10.1136/archdischild-2021-323254. Epub 2022 Dec 12.
9
PAnTher Cub: procalcitonin-guided antibiotic therapy for febrile neutropenia in children and young people with cancer - a single-arm pilot study.PAnTHER Cub 研究:降钙素原指导儿童和青少年癌症中性粒细胞减少性发热患者的抗生素治疗——一项单臂先导研究。
BMJ Paediatr Open. 2022 Mar;6(1). doi: 10.1136/bmjpo-2021-001339.
10
Predictors of Septic Shock or Bacteremia in Children Experiencing Febrile Neutropenia Post-Chemotherapy.化疗后中性粒细胞减少症发热儿童发生感染性休克或菌血症的预测因素。
J Pediatric Infect Dis Soc. 2022 Dec 5;11(11):498-503. doi: 10.1093/jpids/piac080.

本文引用的文献

1
Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules.癌症合并发热性中性粒细胞减少症患儿的风险分层:九种临床决策规则的全国性、前瞻性、多中心验证
EClinicalMedicine. 2020 Jan 7;18:100220. doi: 10.1016/j.eclinm.2019.11.013. eCollection 2020 Jan.
2
Individual participant data validation of the PICNICC prediction model for febrile neutropenia.发热性中性粒细胞减少症 PICNICC 预测模型的个体参与者数据验证。
Arch Dis Child. 2020 May;105(5):439-445. doi: 10.1136/archdischild-2019-317308. Epub 2019 Nov 5.
3
Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice.癌症患儿发热与中性粒细胞减少的管理:澳大利亚和新西兰实践调查
J Paediatr Child Health. 2018 Jul;54(7):761-769. doi: 10.1111/jpc.13899. Epub 2018 Apr 14.
4
Precision medicine in pediatric oncology.儿科肿瘤精准医学。
Curr Opin Pediatr. 2018 Feb;30(1):17-24. doi: 10.1097/MOP.0000000000000570.
5
Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.左氧氟沙星预防小儿急性淋巴细胞白血病诱导治疗期间。
Clin Infect Dis. 2017 Nov 13;65(11):1790-1798. doi: 10.1093/cid/cix644.
6
Safety and cost benefit of an ambulatory program for patients with low-risk neutropenic fever at an Australian centre.澳大利亚中心一项针对低危中性粒细胞减少性发热患者的门诊项目的安全性和成本效益。
Support Care Cancer. 2018 Mar;26(3):997-1003. doi: 10.1007/s00520-017-3921-3. Epub 2017 Oct 10.
7
External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules.六种儿科发热伴中性粒细胞减少症临床决策规则的外部验证。
Pediatr Infect Dis J. 2018 Apr;37(4):329-335. doi: 10.1097/INF.0000000000001777.
8
Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study.预测癌症患儿的感染并发症:一项外部验证研究。
Br J Cancer. 2017 Jul 11;117(2):171-178. doi: 10.1038/bjc.2017.154. Epub 2017 Jun 13.
9
Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.儿童癌症和造血干细胞移植受者发热与中性粒细胞减少管理指南:2017 年更新版。
J Clin Oncol. 2017 Jun 20;35(18):2082-2094. doi: 10.1200/JCO.2016.71.7017. Epub 2017 May 1.
10
Validation of risk stratification for children with febrile neutropenia in a pediatric oncology unit in India.印度一家儿科肿瘤病房中发热性中性粒细胞减少症患儿风险分层的验证
Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26333. Epub 2016 Nov 15.